Canada markets open in 55 minutes

Khiron Life Sciences Corp. (KHRNF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.3700-0.0052 (-1.39%)
At close: 3:59PM EDT
Currency in USD

Valuation Measures

Market Cap (intraday) 542.62M
Enterprise Value 343.56M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.85
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.95
52-Week Change 3-76.58%
S&P500 52-Week Change 314.75%
52 Week High 31.6200
52 Week Low 30.2161
50-Day Moving Average 30.3917
200-Day Moving Average 30.4695

Share Statistics

Avg Vol (3 month) 3137.89k
Avg Vol (10 day) 386.36k
Shares Outstanding 5116.1M
Float 94.36M
% Held by Insiders 117.63%
% Held by Institutions 12.28%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Mar. 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-35.28%
Return on Equity (ttm)-68.80%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)-9.10%
Gross Profit (ttm)2.44M
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)-0.3020
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)4.77
Current Ratio (mrq)5.19
Book Value Per Share (mrq)0.20

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A